home / stock / alrn / alrn news


ALRN News and Press, Aileron Therapeutics Inc. From 10/26/20

Stock Information

Company Name: Aileron Therapeutics Inc.
Stock Symbol: ALRN
Market: NASDAQ
Website: aileronrx.com

Menu

ALRN ALRN Quote ALRN Short ALRN News ALRN Articles ALRN Message Board
Get ALRN Alerts

News, Short Squeeze, Breakout and More Instantly...

ALRN - Lianluo Smart, Galera Therapeutics leads healthcare gainers; BioSig Technologies, Aileron Therapeutics among major losers

Gainers: Lianluo Smart (LLIT) +30%, Galera Therapeutics (GRTX) +18%, Selecta Biosciences (SELB) +16%, Mirati Therapeutics (MRTX) +14%, GeoVax Labs (GOVX) +14%.Losers: BioSig Technologies (BSGM) -40%, Aileron Therapeutics (ALRN) ...

ALRN - DNKN, JMIA among premarket gainers

Lianluo Smart (LLIT) +80% after announcing merger agreement with Newegg.Muscle Maker (GRIL) +80%.Document Security Systems (DSS) +59%.Smart Sand (SND) +26%.Dunkin' Brands Group (DNKN) +17% after confirming takeover discussions with Inspire Brands.Esports Entertainment Grou...

ALRN - Aileron Therapeutics reports positive proof-of-concept data from early-stage ALRN-6924 study in lung cancer

Aileron Therapeutics (ALRN) announces new clinical data from its ongoing Phase 1b trial demonstrating that treatment with ALRN-6924 prior to second-line topotecan administration resulted in a protective effect against chemotherapy-induced bone marrow toxicities in patients with p53-...

ALRN - 5 Penny Stocks On Robinhood To Buy Under $2; Are They Too Risky?

Looking For Penny Stocks On Robinhood? 4 To Watch This Week Whether you’re looking for penny stocks on Robinhood , Webull, TD, Etrade, Interactive Brokers, or any of the other online trading platforms, the goal’s the same. Make money then repeat the process. That might...

ALRN - Stocks To Watch: Big Test For Tech, New IPOs And Fisker Blaze In

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

ALRN - Aileron Therapeutics Announces Proof-of-Concept Clinical Data from Ongoing ALRN-6924 Phase 1b Trial Presented in Late-Breaking Presentation at the EORTC-NCI-AACR Annual Symposium

First and only chemoprotective therapy in clinical development that utilizes a biomarker strategy designed to protect patients with p53-mutated cancers from chemotherapy-induced toxicities and side effects Treatment with ALRN-6924 prior to topotecan administration resulted in a protec...

ALRN - Cassava Sciences, Medigus leads healthcare gainers, Neovasc, ProPhase Labs among major losers

Gainers: Cassava Sciences (SAVA) +13%, Medigus (MDGS) +10%, STRATA Skin Sciences (SSKN) +9%, CASI Pharmaceuticals (CASI) +8%, BOQI International Medical (BIMI) +7%.Losers: Neovasc (NVCN) -14%, ProPhase Labs (PRPH) -14%, Mileston...

ALRN - Selecta Biosciences, Haemonetics leads healthcare gainers; Anchiano Therapeutics, Iterum Therapeutics among major losers

Gainers: Selecta Biosciences (SELB) +18%, Haemonetics (HAE) +12%, Healthcare Services Group (HCSG) +11%, Phreesia (PHR) +10%, ProPhase Labs (PRPH) +9%.Losers: Anchiano Therapeutics (ANCN) -21%, Iterum Therapeutics (ITRM) -13%, Aileron The...

ALRN - Looking For Top Penny Stocks To Buy Today? 3 With Bullish Ratings

Would You Buy These Penny Stocks Based On Analyst Ratings? Penny stocks are some of the fastest moving names in the stock market. It might be stocks under 10 cents or a $4 stock. Whatever the case may be, traders buy and sell these with a simple goal, which is to make quick mone...

ALRN - Aileron Therapeutics to Host Conference Call to Discuss Results from Phase 1b Proof-of-Concept Study of Chemoprotective Therapy ALRN-6924 Being Presented at EORTC-NCI-AACR Annual Symposium

WATERTOWN, Mass., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN) today announced that it will host a conference call and live webcast to discuss results from a Phase 1b proof-of-concept study of ALRN-6924 on Monday, October 26, 2020 at 8:30 a.m. ET. As previously an...

Previous 10 Next 10